|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 抗心律失常药物临床药理学概述显示文摘依照抗心律失常作用进行分类颇为适用,但有很大局限性,因为某一药物及其代谢产物有多种作用,Ⅰ类作用药物是抑制内向快速除极钠流从而延缓动作电位(0相)上升速率的局部麻醉剂。再按抑制钠通道的强度,以及药物对于动作电位、传导速率及复极的作用,进一步分为 IA、IB 及 IC 亚类。Ⅲ类作用药物延长复极及不应期。因抗心律失常药物作用广泛,所以安全有效的治疗要求熟悉所给予的每种药物的药理学特性,并仔细评估病人的现状及病史。联合用药,例如 IA 类和 IB类合用,延缓传导的作用增强,延长不应期,而副作用最小。 | Woosley RL 陈秀云 | 1989 | 国外医学(心血管疾病分册)1989，16，4： | 2 |
| 2 | Gadolinium decreases stretch- induced vulnerability to atrial fibrillation显示文摘 | Bode F Katchman A Woosley RL | 2000 | Circulation2000，101，18： | 2 |
| 3 | Gadolinium decreases stretch- induced vulnerability to atrial fibrillation显示文摘 | Bode F Katchman A Woosley RL | 2000 | Circulation2000，101，18： | 1 |
| 4 | 抗心律失常药物疗效的临床评价显示文摘本专集由六篇论文组成,分别从初始剂量选择、血浆浓度监测、Holter 监测、运动试验、心电图监测和电生理测试等方面,阐述了近年来抗心律失常药物疗效临床评价的发展趋势。 | Woosley RL 戎卫海 | 1989 | 国外医学(心血管疾病分册)1989，16，6： | 1 |
| 5 | Deter- mination of clemastine in human plasma by gas chromatography with nitrogen-phosphorus detection 显示文摘 | DAVYDOVA NN YASUDA SU WOOSLEY RL | 2000 | J Chromatogr B2000，744，1： | 1 |
| 6 | QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system 显示文摘 | PEARSON EC WOOSLEY RL | 2005 | Pharmacoepidemiol Drug Saf2005，14，11： | 1 |
| 7 | Effect of ketoconazlole on QTc显示文摘 | Hewett J Woosley RL | 1994 | Clin Pharmacol Ther1994，55，： | 1 |
| 8 | Mechanism of the cardiotoxic actions of terfenadine显示文摘 | Woosley RL Chen Y Freiman Jea | 1993 | JAMA1993，256，12： | 1 |
| 9 | (S)-Mephenytoin hydroxylation phenotypes in a Jordanian population 显示文摘 | Irshaid YM Woosley RL | 1995 | Clin Pharmacol Ther1995，58，： | 1 |
| 10 | Gadolinium decreases stretch- induced vulnerability to atrial fibrillation显示文摘 | Bode F Katchman A Woosley RL | 2000 | Circulation2000，101，18： | 1 |
| 11 | Incidence and clinical fea- tures of the quinidine - associated long QT syndrome : Implications for patient care显示文摘 | Roden DM Woosley RL Primm RK | 1986 | Am Heart J1986，111，6： | 1 |
| 12 | Changes in the pharmacokinetics and elec trocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin显示文摘 | HONIG PK WOOSLEY RL ZAMAIN K | 1992 | Clin Pharmacol Ther1992，51，2： | 1 |
| 13 | Cardiac actions of antihistamines 显示文摘 | Woosley RL | 1996 | Annu Rev Pharmacol Toxicol1996，36，： | 1 |
| 14 | One hundred years of drug regulation: where do we go from here? 显示文摘 | WOOSLEY RL | 2013 | Annu Rev Pharmacol Toxicol2013，53，： | 1 |
| 15 | Gadofinium decreases stretch- induced vulnerabihty to atrial fibrillation显示文摘 | Bode F Katchman A Woosley RL | 2000 | Circulation2000，101，18： | 1 |
| 16 | Mechanism of the cardiotoxic actions of terfenadine显示文摘 | Woosley RL Chert Y Freiman JP | 1993 | JAMA1993，269，： | 1 |
| 17 | Cardiac action of antihistamines 显示文摘 | WOOSLEY RL | 1996 | Annu Rev Pharmacol Toxicol1996，36，： | 1 |
| 18 | Changes in the pharmacokinetics and electrocardiograhic pharmacodynamics of terfenadine with concomitant administration of erythromycin显示文摘 | Honig PK Woosley RL Zamani K | 1992 | Clin Pharmacol Ther1992，52，： | 1 |
| 19 | Mechanism of the cardiotoxie actions of terfenadine显示文摘 | WOOSLEY RL CHEN Y FRELMA JP | 1993 | JAMA1993，269，： | 1 |
| 20 | Changes in the phannacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin显示文摘 | Honig PK Woosley RL Zamani K | 1992 | Clin Pharmacol Ther1992，52，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员